D-cycloserine is an antibiotic which targets sequential bacterial cell wall peptidoglycan biosynthesis enzymes: alanine racemase and D-alanine:D-alanine ligase. By a combination of structural, chemical and mechanistic studies here we show that the inhibition of D-alanine:D-alanine ligase by the antibiotic D-cycloserine proceeds via a distinct phosphorylated form of the drug. This mechanistic insight reveals a bimodal mechanism of action for a single antibiotic on different enzyme targets and has significance for the design of future inhibitor molecules based on this chemical structure
Prolonging the clinical effectiveness of β-lactams, which remain first-line antibiotics for many inf...
The lack of novel antimicrobial drugs under development coupled with the increasing occurrence of re...
In this review, we summarize the recent literature on dapE-encoded N-succinyl-l,l-diaminopimelic aci...
D-cycloserine is an effective second line antibiotic used as a last resort to treat multi (MDR)- and...
D-alanine:D-alanine ligase (EC 6.3.2.4; Ddl) catalyzes the ATP-driven ligation of two D-alanine (D-A...
As the phenomenon of antibiotic resistance is dramatically increasing these days, the search for new...
There is a growing interest towards the development of new antibiotics from last decades due to emer...
BACKGROUND: ATP-dependent D-alanine:D-alanine ligase (Ddl) is a part of biochemical machinery involv...
AbstractBackground: d-Alanine:d-alanine ligase is essential for bacterial cell wall synthesis, assem...
This article reviews the structures and biological activities of several classes of uridine-containi...
Staphylococcus aureus is an opportunistic Gram-positive bacterium which causes a wide variety of dis...
d-Cycloserine is a second-line drug approved for use in the treatment of patients infected with <i>M...
The single-celled pathogens Mycobacterium tuberculosis and Trypanosoma cruzi are the causative agent...
The rising antimicrobial resistance to antibiotics is a major global problem, which has been exacerb...
D-Cycloserine (DCS) targets the peptidoglycan biosynthetic enzymes D-alanine racemase (Alr) and Dala...
Prolonging the clinical effectiveness of β-lactams, which remain first-line antibiotics for many inf...
The lack of novel antimicrobial drugs under development coupled with the increasing occurrence of re...
In this review, we summarize the recent literature on dapE-encoded N-succinyl-l,l-diaminopimelic aci...
D-cycloserine is an effective second line antibiotic used as a last resort to treat multi (MDR)- and...
D-alanine:D-alanine ligase (EC 6.3.2.4; Ddl) catalyzes the ATP-driven ligation of two D-alanine (D-A...
As the phenomenon of antibiotic resistance is dramatically increasing these days, the search for new...
There is a growing interest towards the development of new antibiotics from last decades due to emer...
BACKGROUND: ATP-dependent D-alanine:D-alanine ligase (Ddl) is a part of biochemical machinery involv...
AbstractBackground: d-Alanine:d-alanine ligase is essential for bacterial cell wall synthesis, assem...
This article reviews the structures and biological activities of several classes of uridine-containi...
Staphylococcus aureus is an opportunistic Gram-positive bacterium which causes a wide variety of dis...
d-Cycloserine is a second-line drug approved for use in the treatment of patients infected with <i>M...
The single-celled pathogens Mycobacterium tuberculosis and Trypanosoma cruzi are the causative agent...
The rising antimicrobial resistance to antibiotics is a major global problem, which has been exacerb...
D-Cycloserine (DCS) targets the peptidoglycan biosynthetic enzymes D-alanine racemase (Alr) and Dala...
Prolonging the clinical effectiveness of β-lactams, which remain first-line antibiotics for many inf...
The lack of novel antimicrobial drugs under development coupled with the increasing occurrence of re...
In this review, we summarize the recent literature on dapE-encoded N-succinyl-l,l-diaminopimelic aci...